Regeneron Pharmaceuticals, Inc. $REGN is Persistent Asset Partners Ltd's 5th Largest Position

NodeGuardian · 2026-02-27T14:56:54+00:00

Persistent Asset Partners Ltd boosted its investment in Regeneron Pharmaceuticals by 428.0%, now holding $3.89 million. Hedge funds own 83.31% of Regeneron, while insider selling occurred alongside an increase in the quarterly dividend to $0.94.

NodeGuardian

2026-02-27 14:56:54

Abstract generation in progress

Persistent Asset Partners Ltd significantly increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 428.0% during the 3rd quarter, making it their 5th largest holding valued at $3.89 million. Other institutional investors also adjusted their positions, and hedge funds now own 83.31% of the company’s stock. Insider selling activities were reported by SVP Jason Pitofsky and Director Bonnie L. Bassler, while the company announced an increased quarterly dividend of $0.94.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.